Spire Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$126K Buy
239
+65
+37% +$36.5K ﹤0.01% 915
2026
Q1
$97.8K Sell
174
-1,943
-92% -$1.25M ﹤0.01% 964
2025
Q4
$1.43M Buy
2,117
+1,940
+1,096% +$1.32M 0.05% 326
2025
Q3
$113K Buy
177
+2
+1% +$1.21K ﹤0.01% 947
2025
Q2
$93.9K Sell
175
-143
-45% -$68.4K ﹤0.01% 992
2025
Q1
$133K Sell
318
-144
-31% -$62.5K ﹤0.01% 933
2024
Q4
$191K Sell
462
-3,046
-87% -$1.34M 0.01% 835
2024
Q3
$1.77M Sell
3,508
-5,598
-61% -$2.72M 0.06% 259
2024
Q2
$4.44M Sell
9,106
-1,593
-15% -$800K 0.16% 134
2024
Q1
$5.78M Sell
10,699
-2,629
-20% -$1.44M 0.1% 138
2023
Q4
$6.98M Buy
13,328
+4,239
+47% +$1.99M 0.23% 90
2023
Q3
$3.97M Buy
9,089
+7,928
+683% +$3.95M 0.15% 150
2023
Q2
$583K Buy
1,161
+201
+21% +$96.3K 0.02% 456
2023
Q1
$480K Buy
960
+648
+208% +$310K 0.02% 501
2022
Q4
$127K Buy
312
+138
+79% +$53.6K 0.01% 667
2022
Q3
$57K Sell
174
-4,570
-96% -$1.68M ﹤0.01% 904
2022
Q2
$1.66M Sell
4,744
-263
-5% -$107K 0.07% 229
2022
Q1
$2.74M Sell
5,007
-46
-0.9% -$24.2K 0.07% 226
2021
Q4
$3.33M Buy
5,053
+3,953
+359% +$2.48M 0.07% 227
2021
Q3
$694K Buy
1,100
+296
+37% +$199K 0.02% 501
2021
Q2
$508K Buy
804
+293
+57% +$162K 0.01% 603
2021
Q1
$250K Buy
+511
New +$256K 0.01% 966

Other funds holding IDXX

Spire Wealth Management's IDXX Position: Q2 2026 in Review

Spire Wealth Management increased its Idexx Laboratories (IDXX) stake by 37% in Q2 2026, buying an estimated $36.5K and bringing the position to 239 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #915.

Spire Wealth Management first reported a position in IDXX in Q1 2021 and has held it in 22 quarters since. The position peaked at $6.98M in Q4 2023. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Spire Wealth Management held 239 shares of Idexx Laboratories worth $126K as of Q2 2026.
  • Spire Wealth Management bought 65 Idexx Laboratories shares in Q2 2026, an estimated $36.5K.
  • Idexx Laboratories made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #915 holding.
  • Spire Wealth Management first reported a position in Idexx Laboratories in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Idexx Laboratories position peaked at $6.98M in Q4 2023.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.